Call 911 or go to the nearest emergency room if a COPD flare brings severe or rapidly worsening breathlessness, an inability to speak in full sentences, bluish lips or fingertips, confusion or unusual drowsiness, a high fever, coughing up blood, or chest pain, or if your rescue inhaler is not helping. These can signal a severe exacerbation or dangerously low oxygen. Do not wait it out at home. Never stop your maintenance inhalers on your own, even when you feel better — stopping them can trigger a flare.
Chronic obstructive pulmonary disease — better known as COPD — is among the top few causes of death worldwide, claiming over 3 million lives each year according to the World Health Organization. In the United States alone, roughly 15 million or more people have been diagnosed, and millions more likely have it without knowing. COPD is a progressive lung disease that gradually steals your ability to breathe — but early detection and proper management can meaningfully slow that progression and improve daily life. For an overview of how chronic conditions like this affect Americans, visit our medical conditions guide. This article is educational and is not a substitute for care from a qualified clinician.
What Is COPD?
COPD is an umbrella term for a group of progressive lung diseases that obstruct airflow and make breathing increasingly difficult. The two conditions most often grouped under it are chronic bronchitis (inflammation and narrowing of the bronchial tubes with excess mucus) and emphysema (destruction of the air sacs in the lungs). Most people with COPD have features of both.
In a healthy lung, air flows freely through the bronchial tubes into tiny air sacs called alveoli, where oxygen passes into the bloodstream and carbon dioxide passes out. In COPD, the airways become inflamed and thickened, the air sacs lose their elasticity, and the walls between them break down. The result is trapped air, reduced oxygen exchange, and the sensation of struggling to breathe.
The word “progressive” is critical. COPD does not get better on its own, and lung damage that has already occurred is largely irreversible. However, treatment can relieve symptoms, slow the rate of decline, reduce flare-ups, and substantially improve quality of life. The National Heart, Lung, and Blood Institute emphasizes that COPD is treatable, and many people with it live active lives for years after diagnosis.
Causes and Risk Factors
Cigarette smoking is the number one cause of COPD, responsible for the large majority of cases in the United States. The toxic chemicals in tobacco smoke trigger chronic airway inflammation and systematically destroy lung tissue over decades. Not every smoker develops COPD — genetics influence susceptibility — but smoking remains the single most important risk factor by a wide margin. Vaping is newer, and its long-term effects on COPD are still being studied; it is not established as a safe substitute for the lungs.
Long-term exposure to other lung irritants also contributes. Secondhand smoke, occupational dust and chemicals (common in mining, construction, and manufacturing), indoor air pollution from biomass fuels used for cooking and heating, and outdoor air pollution all increase risk. In many lower-income countries, indoor air pollution is a leading cause of COPD, particularly among women.
A genetic condition called alpha-1 antitrypsin deficiency accounts for a small share of COPD cases. People with it lack enough of a protein that protects the lungs from damage by their own inflammatory enzymes. The CDC notes this deficiency is uncommon but underrecognized. If you develop COPD at a young age or without a significant smoking history, your doctor should test for it — a simple blood test — because it changes management and has family-screening implications.
Why Some Non-Smokers Get COPD
A meaningful share of COPD — often cited as around 1 in 4 cases worldwide, and roughly 10 to 15 percent in the United States — occurs in people who have never smoked. Childhood respiratory infections, chronic or poorly controlled asthma, occupational exposures, and air pollution all contribute. Research from the NIH also suggests that impaired lung development in childhood — from premature birth, poor nutrition, or repeated infections — may predispose people to COPD later in life, even without smoking.
Recognizing COPD Symptoms
COPD symptoms develop slowly and often go unnoticed until significant lung damage has occurred. Many people dismiss early signs as normal aging or being “out of shape.” The hallmark symptoms are a persistent cough (often called “smoker’s cough”), excess sputum or mucus, and shortness of breath — especially during physical activity.
As the disease progresses, breathlessness occurs with less and less exertion. You may find yourself avoiding stairs, struggling to carry groceries, or needing to pause during short walks. Wheezing, chest tightness, frequent respiratory infections, fatigue, and unintended weight loss (in advanced stages) are also common. Some people notice a bluish tint to their lips or fingernail beds (cyanosis), a sign of low blood oxygen that warrants urgent evaluation.
COPD exacerbations — flare-ups — are episodes where symptoms suddenly worsen beyond normal day-to-day variation. They are often triggered by respiratory infections, air pollution, or allergens. Exacerbations can be mild or severe enough to require hospitalization, and each one can accelerate the decline in lung function and raise future risk. According to the Mayo Clinic, recognizing and treating exacerbations quickly is one of the most important parts of COPD management — and the most severe flares, listed in the red-flag box above, are emergencies.
COPD Stages: The GOLD Classification
COPD severity is graded using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) system, based partly on spirometry — a breathing test that measures how much air you can force out in one second (FEV1) compared with the predicted value for your age, height, and sex.
- GOLD 1 (Mild): FEV1 is 80% or more of predicted. Symptoms may be minimal, and many people are undiagnosed at this stage.
- GOLD 2 (Moderate): FEV1 is 50–79% of predicted. Shortness of breath on exertion becomes noticeable, and people often seek care here.
- GOLD 3 (Severe): FEV1 is 30–49% of predicted. Breathlessness significantly limits daily activities, and exacerbations become more frequent.
- GOLD 4 (Very Severe): FEV1 is below 30% of predicted. Quality of life is severely affected, and exacerbations can be life-threatening.
Spirometry alone does not tell the whole story, so GOLD also groups patients by their symptom burden and exacerbation history using the ABE assessment (the current framework, which replaced the older four-box ABCD system). In simple terms: group A is fewer symptoms and low exacerbation risk, group B is more symptoms with low exacerbation risk, and group E denotes people with a history of frequent or severe exacerbations, regardless of symptom level. Two people with the same FEV1 can have very different experiences, and this combined picture — not spirometry alone — guides which treatments are recommended.
Diagnosis
Spirometry is the gold standard for diagnosing COPD. It is a simple, noninvasive test in which you blow into a mouthpiece as hard and as long as you can. The key measurement is the ratio of FEV1 to FVC (forced vital capacity, the total air you can exhale). A ratio below 0.70 after using a bronchodilator confirms the airflow obstruction that defines COPD.
Your doctor will also take a detailed history — smoking history (measured in “pack-years”), occupational exposures, family history, and symptom timeline. A chest X-ray or CT scan may be ordered to rule out other conditions and look for emphysema. Arterial blood gas testing can measure oxygen and carbon dioxide in the blood, and pulse oximetry provides a quick, noninvasive oxygen reading.
The NHLBI recommends that anyone with risk factors and respiratory symptoms be tested with spirometry. Despite this, COPD remains significantly underdiagnosed. If you have a chronic cough, produce mucus regularly, or get winded easily — particularly if you smoke or used to — ask your doctor about testing rather than assuming it is just age.
Treatment: Medications
There is no cure for COPD, but medications can control symptoms and reduce exacerbations. All of them are chosen and dosed by a clinician; this guide names medication types for understanding but does not provide doses. Bronchodilators are the cornerstone of treatment. These inhaled medicines relax the muscles around the airways to make breathing easier. Short-acting bronchodilators (such as albuterol) give quick relief, while long-acting bronchodilators are used daily for maintenance.
For people with more symptoms or frequent exacerbations, inhaled corticosteroids (ICS) are sometimes added to a long-acting bronchodilator, often guided by blood eosinophil levels and flare history. Combination inhalers containing a long-acting bronchodilator plus ICS — or triple-therapy inhalers with two bronchodilators plus ICS — simplify regimens and improve adherence. The Mayo Clinic notes the inhaler choice should be individualized based on symptom severity, exacerbation frequency, and response — and using inhalers with correct technique is as important as the prescription itself.
Oral medications like roflumilast (a phosphodiesterase-4 inhibitor) can reduce exacerbations in severe COPD with chronic bronchitis, and long-term low-dose azithromycin helps reduce flares for some patients. Oral corticosteroids are reserved mainly for acute exacerbations because of significant side effects with long-term use. Two newer additions are worth knowing about: ensifentrine, an inhaled dual PDE3/PDE4 inhibitor approved in 2024 as a maintenance option, and dupilumab (Dupixent), a biologic injection approved in 2024 as an add-on maintenance treatment for certain people with COPD driven by type 2 (eosinophilic) inflammation who still have flares despite inhaler therapy. These are specialist-directed decisions, not something to start on your own.
Treatment: Beyond Medications
Pulmonary Rehabilitation
Pulmonary rehabilitation is one of the most effective interventions for COPD, yet it remains vastly underused. These structured programs combine supervised exercise training, education, breathing techniques, nutritional counseling, and psychological support. Studies consistently show that pulmonary rehab improves exercise capacity, reduces breathlessness, decreases hospitalizations, and enhances quality of life. Major respiratory societies consider it a standard of care for people with moderate-to-severe COPD, and it is especially valuable in the weeks after a hospitalization for a flare.
Oxygen Therapy
Supplemental oxygen is prescribed when blood oxygen levels drop below a defined threshold. Long-term oxygen therapy — used for many hours each day, typically at least 15 — has been shown to improve survival in people with severe COPD and chronically low oxygen levels. Portable oxygen concentrators allow many people to stay active and mobile while receiving oxygen. Oxygen flow settings should always be set by a clinician, not adjusted on your own.
Surgical and Bronchoscopic Options
For selected patients with severe emphysema, procedures may help. Lung volume reduction surgery removes damaged portions of lung so healthier tissue can work more effectively, and bullectomy removes large air-filled spaces that compress normal lung. A less invasive option, bronchoscopic lung volume reduction using one-way endobronchial valves, is available for some patients and avoids open surgery. Lung transplantation is a last resort for the most severe cases in eligible candidates.
Quitting Smoking: The Single Most Important Step
If you smoke and have COPD, quitting is the one intervention proven to slow the rate of lung-function decline. Nothing else — no medication, no surgery — matches the impact of smoking cessation on the long-term trajectory of the disease. According to the CDC, quitting at any stage of COPD provides benefit, and it is never too late.
Nicotine replacement therapy (patches, gum, lozenges), prescription medicines like varenicline and bupropion, counseling, and quit-lines all improve success rates — and these should be used under a clinician’s guidance rather than self-directed. Combining medication with behavioral support gives you the best chance. Most people need several attempts before quitting for good, so if you have tried and slipped, try again with a different approach.
Avoiding secondhand smoke and other lung irritants is equally important. If your workplace exposes you to dust, fumes, or chemicals, discuss protective measures or accommodations with your employer.
Preventing Exacerbations
Exacerbations are the enemy. Each one can damage your lungs further, reduce your quality of life, and raise your risk of hospitalization and death. Prevention starts with taking maintenance medications consistently and staying current on recommended vaccines — annual influenza vaccination, COVID-19 vaccination as advised, pneumococcal (pneumonia) vaccination, and RSV vaccination, which is now recommended for many older adults and can help prevent a common trigger of severe flares. Review your vaccination status with your clinician.
Practicing good hand hygiene, avoiding crowds during respiratory-illness season, monitoring air quality and staying indoors on high-pollution days, and having a plan for early flare symptoms are all practical steps. Many doctors provide a written COPD action plan that spells out exactly what to do when symptoms begin to worsen — including when to step up treatment and when to seek emergency care — so that treatment starts early rather than after a crisis.
Frequently Asked Questions
Can COPD be cured?
There is currently no cure for COPD, and lung damage that has already occurred cannot be reversed. However, treatment can significantly relieve symptoms, slow progression, reduce exacerbations, and improve quality of life. Quitting smoking and following your treatment plan are the most effective ways to manage the disease long-term.
How long can you live with COPD?
Life expectancy with COPD varies widely depending on severity at diagnosis, whether you continue smoking, how well you respond to treatment, and your overall health. Many people with mild-to-moderate COPD live for decades after diagnosis. The BODE index — which considers body mass index, airflow obstruction, dyspnea, and exercise capacity — is one tool doctors use to estimate prognosis, but it is only an estimate, and good management can improve the outlook.
Is COPD the same as asthma?
No. While both are obstructive lung diseases, they differ in important ways. Asthma typically starts in childhood, involves largely reversible airway obstruction, and is driven by allergic or immune responses. COPD usually develops after age 40, causes mostly irreversible obstruction, and is chiefly caused by smoking or long-term irritant exposure. Some people have features of both, sometimes called asthma-COPD overlap.
What does a COPD cough sound like?
A COPD cough is typically persistent and productive, meaning it brings up mucus (sputum). It may sound wet, rattling, or deep, and it is often worst in the morning. Unlike a temporary cough from a cold, it lasts for months or years. If you have had a cough producing mucus on most days for at least three months in two consecutive years, you meet the clinical definition of chronic bronchitis — a reason to get evaluated.
Can you get COPD without smoking?
Yes. While smoking causes most cases, a substantial minority of people with COPD have never smoked. Causes include long-term secondhand smoke, occupational dust and chemicals, indoor and outdoor air pollution, alpha-1 antitrypsin deficiency, and a history of childhood respiratory infections or poorly controlled asthma. Non-smokers with persistent respiratory symptoms deserve testing too.
What are the newest COPD treatments?
Recent years have added options beyond traditional inhalers, including an inhaled maintenance medication (ensifentrine) approved in 2024 and the first biologic for COPD, dupilumab, also approved in 2024 for certain people with eosinophilic COPD who keep having flares. Bronchoscopic valve procedures help some people with severe emphysema. These are all clinician-directed; whether any is right for you depends on your specific disease pattern and test results.
Taking Control of Your COPD
Living with COPD requires active management, but it does not require giving up the things that matter to you. Work closely with your clinician to optimize your medication regimen and check your inhaler technique. Enroll in pulmonary rehabilitation — the evidence for its benefits is overwhelming. Stay physically active within your limits, eat a nutritious diet to maintain muscle strength, and address anxiety and depression, which often accompany chronic lung disease.
Learn your triggers and avoid them. Keep a written action plan visible and share it with family members so they know the warning signs. Stay up to date on vaccinations. And if you are still smoking, make quitting your top priority — it is the single most powerful thing you can do to change the course of your disease. If cost or coverage is a barrier to inhalers, oxygen, or rehab, our healthcare costs guide outlines options and assistance programs. The tools and support available today give you a real chance at a meaningful, active life with COPD.
This article is general education, not medical advice, and is not a substitute for care from a qualified clinician. COPD requires individualized, clinician-directed treatment, and inhalers, oxygen, and other medicines must be prescribed and adjusted by your provider — never started or stopped on your own. If a flare brings severe breathlessness, an inability to speak in full sentences, bluish lips, confusion or drowsiness, high fever, coughing up blood, or chest pain, call 911 or go to the nearest emergency room.
Sources
- NHLBI (National Heart, Lung, and Blood Institute), COPD — nhlbi.nih.gov
- GOLD (Global Initiative for Chronic Obstructive Lung Disease), Latest Report — goldcopd.org
- CDC (Centers for Disease Control and Prevention), COPD — cdc.gov
- Mayo Clinic, COPD: Symptoms and Causes — mayoclinic.org
- WHO (World Health Organization), COPD Fact Sheet — who.int